Literature DB >> 31961800

Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.

S H Donze1,2, L Damen1,2, E F Mahabier1, A C S Hokken-Koelega1,2.   

Abstract

OBJECTIVE: Children with Prader-Willi syndrome (PWS) have mild to moderate cognitive impairment. Short-term studies showed positive effects of growth hormone (GH) on cognitive development. This study investigated the effects of 8 years of GH on cognitive development in children with PWS. We also investigated whether starting GH during infancy results in higher cognitive functioning after 8 years of GH.
DESIGN: Longitudinal study in 43 children with PWS during 8 years of GH (median age at GH start 8.1 years). Cognitive functioning after 8 years was compared to another group of 22 children with PWS (median age at GH start 1.4 years).
METHODS: Cognitive functioning was measured by Wechsler Intelligence Scale for Children. Vocabulary, Similarities and Block Design subtests were expressed as standard deviation scores (SDS) and total IQ (TIQ) calculated.
RESULTS: Estimated mean (95%CI) Block Design SDS changed from -2.2 (-2.6; -1.8) at GH start to -1.8 (-2.2; -1.4) after 8 years of GH (P = 0.18), similarly SDS from -1.5 (-2.1; -0.9) to -1.3 (-1.9; -0.7, P = 0.66) and TIQ from 66 (60; 72) to 69 (63; 75, P = 0.57). Vocabulary SDS remained similar, being -1.9 (-2.3; -1.4) at GH start and -1.9 (-2.4; -1.5) after 8 years (P = 0.85). After 8 years of GH Vocabulary, SDS and TIQ were higher in the children who started GH during infancy, compared to those who started GH later in childhood (P < 0.01, P = 0.04, respectively).
CONCLUSIONS: Cognitive functioning in children with PWS remains similar during long-term GH and develops at the same pace as healthy peers.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31961800     DOI: 10.1530/EJE-19-0479

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

1.  Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?

Authors:  Lionne N Grootjen; Demi J Trueba-Timmermans; Layla Damen; Eva F Mahabier; Gerthe F Kerkhof; Anita C S Hokken-Koelega
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

2.  Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome.

Authors:  Lionne N Grootjen; Nathalie E M Uyl; Inge A L P van Beijsterveldt; Layla Damen; Gerthe F Kerkhof; Anita C S Hokken-Koelega
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

3.  Cognitive and Adaptive Effects of Early Growth Hormone Treatment in Prader-Willi Syndrome Patients: A Cohort Study.

Authors:  Aitana Ayet-Roger; Lorena Joga-Elvira; Assumpta Caixàs; Raquel Corripio
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

Review 4.  Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future.

Authors:  Evan Graber; Edward O Reiter; Alan D Rogol
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.